Table 2 Demographics of study populations
Baseline characteristics | ACTG cohort (n = 102) | BLIR study cohort (n = 20) | Total (n = 122) | |
|---|---|---|---|---|
Age (years) | 39 (18 – 64) | 37 (30 – 51) | 39 (18 – 64) | |
Sex | Female | 21 (21%) | 3 (15%) | 24 (20%) |
Male | 81 (79%) | 17 (85%) | 98 (80%) | |
Race | Caucasian Non-Hispanic | 51 (50%) | 5 (25%) | 56 (46%) |
African American Non-Hispanic | 19 (19%) | 14 (70%) | 33 (27%) | |
Hispanic | 30 (29%) | 1 (5%) | 31 (25%) | |
Other | 2 (2%) | 0 | 2 (2%) | |
BMI | 25.7 (18.6 – 47.2) | 23.3 (18.9 – 35.5) | 25.4 (18.6 – 47.2) | |
Prior Smoking History | Yes | 52 (51%) | 16 (80%) | 68 (56%) |
No | 50 (49%) | 4 (20%) | 54 (44%) | |
CD4+ T-cells (cells/mm3) | 288 (8 – 980) | 72.5 (3 – 268) | 256 (3 – 980) | |
Viral load (log10RNA copies/mL) | 4.61 (2.28 – 5.99) | 5.3 (2.15 – 6.14) | 4.67 (2.15 – 6.14) | |
ART Regimen | NNRTI + NRTI | 42 (41%) | 0 | 42 (34) |
PI + NRTI | 39 (38%) | 20 (100%) | 59 (48%) | |
RAL + NRTI | 19 (19%) | 0 | 19 (16%) | |
Other | 2 (2%) | 0 | 2 (2) | |
HBV Infection | Positive | 1 (1%) | No data | No data |
Negative | 101 (99%) | No data | No data | |
HCV Infection | Positive | 3 (3%) | No data | No data |
Negative | 99 (97%) | No data | No data | |